Bokhari Aqiba, Tiscornia-Wasserman Patricia G
Division of Cytopathology, Department of Pathology and Cell Biology, New York Presbyterian-Columbia University Medical Center, New York, New York.
Diagn Cytopathol. 2017 Feb;45(2):161-167. doi: 10.1002/dc.23619. Epub 2016 Oct 22.
Renal cell carcinoma metastases to pancreas, thyroid, and contralateral adrenal gland are decidedly uncommon. Clear cell renal cell carcinoma (CCRCC) is the most frequent subtype. Cytology diagnosis may be challenging. A 74-year-old male with remote history of vocal cord malignancy and hypertension presented with abdominal pain. Computed tomography (CT) revealed 8.4 cm left renal mass highly suspicious for renal cell carcinoma, a 1.8 cm mass within vessels near left adrenal and a 2.5 cm mass in pancreatic tail. Right pulmonary middle lobe showed two small nodules. Metastatic CCRCC was diagnosed on preoperative transgastric, endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic tail mass. Left radical nephrectomy and distal pancreatectomy and splenectomy confirmed CCRCC (pT3bNxM1), with metastases in adrenal and pancreatic tail. The 3p deletion identification in pancreatic tumor suggested CCRCC origin. Follow-up positron emission tomography-CT (PET-CT) scan revealed left thyroid lower pole mass. Thyroid ultrasound showed three clustered 6 mm nodules in left mid pole. Ultrasound-guided fine needle aspiration (US-FNA) biopsies, 4-month post-nephrectomy, were consistent with metastatic renal cell carcinoma in lower, and atypia of undetermined significance in mid poles respectively. Left lobectomy and isthmus and pyramidal lobe resections confirmed metastatic renal cell carcinoma. One year post-radical nephrectomy, contralateral adrenal lesion noted on PET-CT was interpreted as metastatic CCRCC on CT-guided core biopsy with touch imprints. Rapid on-site evaluation was implemented, and immunoprofile typical of CCRCC substantiated cytomorphology at all three sites. Previously reported cases of renal cell carcinoma metastases to organs as in the described case are reviewed as well. Diagn. Cytopathol. 2017;45:161-167. © 2016 Wiley Periodicals, Inc.
肾细胞癌转移至胰腺、甲状腺和对侧肾上腺实属罕见。透明细胞肾细胞癌(CCRCC)是最常见的亚型。细胞学诊断可能具有挑战性。一名74岁男性,有声带恶性肿瘤和高血压病史,现出现腹痛。计算机断层扫描(CT)显示左肾有一个8.4 cm的肿块,高度怀疑为肾细胞癌,左肾上腺附近血管内有一个1.8 cm的肿块,胰尾有一个2.5 cm的肿块。右肺中叶有两个小结节。术前经胃、内镜超声引导下对胰尾肿块进行细针穿刺细胞学检查,诊断为转移性CCRCC。左根治性肾切除术、远端胰腺切除术和脾切除术证实为CCRCC(pT3bNxM1),肾上腺和胰尾有转移。胰腺肿瘤中3p缺失的鉴定提示为CCRCC起源。随访正电子发射断层扫描-CT(PET-CT)显示左甲状腺下极有肿块。甲状腺超声显示左中极有三个聚集的6 mm结节。肾切除术后4个月,超声引导下细针穿刺活检(US-FNA)结果分别显示下极符合转移性肾细胞癌,中极符合意义未明的非典型病变。左叶切除术及峡部和锥状叶切除术证实为转移性肾细胞癌。根治性肾切除术后1年,PET-CT上发现的对侧肾上腺病变经CT引导下穿刺活检及触摸印片诊断为转移性CCRCC。进行了快速现场评估,所有三个部位的免疫表型均显示为典型的CCRCC,证实了细胞形态学。本文还回顾了既往报道的与该病例类似的肾细胞癌转移至器官的病例。诊断细胞病理学。2017;45:161 - 167。© 2016威利期刊公司